Evaluating the Incremental Benefit of Two Versus One Dose of Influenza Vaccine in Influenza-Naive Children Under Nine: A Systematic Review and Meta-Analysis
WHO recommends two influenza vaccine doses for vaccine-naive children under 9 based on immunogenicity evidence.
The meta-analysis shows a 28 percentage point increase in vaccine effectiveness with two doses in children under 3 years old.
For children under 9, the additional protection from a second inactivated vaccine dose was 15 percentage points but did not reach statistical significance.
There is insufficient evidence on incremental benefits of second doses for live attenuated influenza vaccines, indicating a need for further high-quality studies.
Study Background and Disease Burden
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
